De Vos, F Y F L <br/><br/>
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Apr 2005 
 - 60-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2004.11.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amifostine--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Nervous System Diseases--chemically induced<br/>Neuroprotective Agents--therapeutic use<br/>Neutropenia--chemically induced<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Quality of Life